A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture.
The continuation of a review of delayed vasospasm after aneurysmal subarachnoid haemorrhage, originally published in 1994 and partially updated at the ninth vasospasm conference in Turkey, is presented. Further online and physical searches have been made of the relevant literature. The incidence of delayed ischaemic deficit (DID) or symptomatic vasospasm reported in 1994 was 32.5% in over 30,000 reported cases. In recent years, 1994-2009, it was 6,775/23,806, or 28.5%. Many of the recent reports did not specify whether a calcium antagonist was used routinely, and when this was stated (usually nimodipine or nicardipine), DID was noted in 22.0% of 10,739 reported patients. The outcome of delayed ischaemia in the earlier survey was a death rate of 31.6%, with favourable outcomes in 36.2%. In recent reports, though with fewer than 1,000 patients, the outcome is possibly better, with death in 25.6% and good outcome in 54.1%. It thus appears likely that delayed vasospasm is still common but less so, and that the overall outcome has improved. This may be due to the more widespread use of calcium antagonists and more effective fluid management. A number of other mechanical and drug treatments are also mentioned.
Department of Neurosurgery, Westmead Hospital, University of Sydney, Sydney, NSW, Australia. ndorsch@ozemail.com.au
Nicholas
N
Dorsch
D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007511:Ischemia / Q000453:epidemiology / Q000209:etiology* / Q000401:mortality / Q000628:therapy*; D013345:Subarachnoid Hemorrhage / Q000150:complications* / Q000453:epidemiology / Q000266:history; D020301:Vasospasm, Intracranial / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy